aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
CryptoMedix LLC, founded with a mission to revolutionize cancer treatment, focuses on the discovery, clinical development, and commercialization of therapeutic products. The company specializes in immuno-oncology, particularly targeting the tumor microenvironment (TME). Their core technology platform involves first-in-class therapeutic antibodies designed to promote the migration and activation of immune cells within tumors, aiming to enhance the body's natural ability to fight cancer.
Notable figures affiliated with CryptoMedix include its founders and key scientific advisors who are experts in biotechnology and oncology. The company has garnered attention and support from prominent investors in the biotech sector. Despite the challenges posed by the COVID-19 pandemic, CryptoMedix has made significant scientific advancements, positioning itself as a leader in the immuno-oncology space. Their innovative approach has the potential to significantly impact cancer treatment outcomes, marking a promising future for both patients and the biotech industry.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Therapeutic Products
Technology
Biotech
Tags
Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was CryptoMedix founded?
CryptoMedix was founded in 2013.
Where is CryptoMedix’s headquarters located?
CryptoMedix’s headquarters is located in Harpswell, ME, US.
When was CryptoMedix’s last funding round?
CryptoMedix’s most recent funding round was for $276.5k (USD) in June 2016.
How many employees does CryptoMedix have?
CryptoMedix has 30 employees as of Feb 5, 2024.
How much has CryptoMedix raised to-date?
As of July 05, 2023, CryptoMedix has raised a total of $276.5k (USD) since Jun 8, 2016.
Add Comparison
Total Raised to Date
$276.5k
USD
Last Update Jun 8, 2016
Last Deal Details
$276.5k
USD
Jun 8, 2016
Convertible Note
Total Employees Over Time
30
As of Feb 2024
CryptoMedix Address
464 Basin Point Rd
Harpswell,
Maine
04079
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts